HotSpot Therapeutics: Funding, Investors & Team (Sep 2026)
HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment. The company's platform helps to identify hotspots and locate pathway treatments for cancer, metabolic and rare diseases, leverages a database of hotspot structures, harnessing the power of data science in its multidisciplinary approach to drug discovery enabling patients to get treatment against several diseases.
HotSpot Therapeutics has raised $165M across 2 funding rounds on record, the most recent a Series C of $100M announced in Nov 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
HotSpot Therapeutics Company Profile and Key Stats
Latest funding round on record: Nov 2021.
HotSpot Therapeutics Funding Rounds
HotSpot Therapeutics raised $65.0M in an undisclosed round announced in May 2020.
1.5 years later, a Series C of $100M was announced in Nov 2021.
HotSpot Therapeutics Founders and Leadership Team
Contact details for the HotSpot Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →HotSpot Therapeutics Funding Compared to Other Biotechnology Startups
HotSpot Therapeutics' latest round of $100M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like HotSpot Therapeutics in Biotechnology and Boston
Companies Similar to HotSpot Therapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
HotSpot Therapeutics Funding FAQs
What does HotSpot Therapeutics do?
HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment. The company's platform helps to identify hotspots and locate pathway treatments for cancer, metabolic and rare diseases, leverages a database of hotspot structures, harnessing the power of data science in its multidisciplinary approach to drug discovery enabling patients to get treatment against several diseases.
How much funding has HotSpot Therapeutics raised?
HotSpot Therapeutics has raised $165M across 2 rounds on record. The most recent is a Series C of $100M announced in Nov 2021.
When did HotSpot Therapeutics last raise funding?
HotSpot Therapeutics' most recent funding round on record is a Series C of $100M, announced in Nov 2021.
Who is the CEO of HotSpot Therapeutics?
Jonathan Montagu is listed as CEO at HotSpot Therapeutics.
Where is HotSpot Therapeutics headquartered?
HotSpot Therapeutics is based in Boston, Massachusetts, United States.
How many employees does HotSpot Therapeutics have?
HotSpot Therapeutics is in the 11-50 employee band.
How does HotSpot Therapeutics' funding compare to other Biotechnology startups?
HotSpot Therapeutics' latest round of $100M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's HotSpot Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for HotSpot Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.